Detailansicht

Wissensnetz

Person

Philipp Köhler (1988-)

Hochschullehrer

Name	Philipp Köhler
Zeit	1988- (Lebensdaten)
Ort	Köln (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	PD Dr.
Beruf	Hochschullehrer (charakteristischer Beruf) Arzt
Variante	Philipp Koehler P. Köhler P. Koehler
Beziehung	Universitätsklinikum Köln. Klinik I für Innere Medizin
Weitere Angaben	Habil., Med. Fak. d. Univ. zu Köln, 24. Juni 2021 Assistenzarzt der Klinik I für Innere Medizin an der Uniklinik Köln und stellvertretender Leiter des Europäischen Exzellenzzentrums für Invasive Pilzinfektionen
Quelle	Homepage Universitätsklinikum Köln: https://innere1.uk-koeln.de/informationen/aktuelles/detailansicht/dr-koehler-erhaelt-nachwuchsfoerderpreis/ (Stand: 24.08.2023)
Datensatztyp	Person
GND-Nummer	1033465666
Datensatz-ID	1033465666
Beteiligt an alle anzeigen The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature In-vitro performance of anti-CD19 engineered T cells correlates with clinical risk parameters for use in adoptive therapy of B-cell chronic lymphocytic leukaemia

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Philipp Köhler (1988-)

The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections

Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature

In-vitro performance of anti-CD19 engineered T cells correlates with clinical risk parameters for use in adoptive therapy of B-cell chronic lymphocytic leukaemia